1. Home
  2. HPH vs SCLX Comparison

HPH vs SCLX Comparison

Compare HPH & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPH
  • SCLX
  • Stock Information
  • Founded
  • HPH 2010
  • SCLX 2011
  • Country
  • HPH China
  • SCLX United States
  • Employees
  • HPH N/A
  • SCLX N/A
  • Industry
  • HPH
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HPH
  • SCLX Health Care
  • Exchange
  • HPH NYSE
  • SCLX Nasdaq
  • Market Cap
  • HPH 50.5M
  • SCLX 51.3M
  • IPO Year
  • HPH 2019
  • SCLX N/A
  • Fundamental
  • Price
  • HPH $0.15
  • SCLX $0.23
  • Analyst Decision
  • HPH
  • SCLX Strong Buy
  • Analyst Count
  • HPH 0
  • SCLX 4
  • Target Price
  • HPH N/A
  • SCLX $14.00
  • AVG Volume (30 Days)
  • HPH 821.7K
  • SCLX 1.1M
  • Earning Date
  • HPH 01-01-0001
  • SCLX 05-12-2025
  • Dividend Yield
  • HPH N/A
  • SCLX N/A
  • EPS Growth
  • HPH N/A
  • SCLX N/A
  • EPS
  • HPH N/A
  • SCLX N/A
  • Revenue
  • HPH $286,996,105.00
  • SCLX $55,152,000.00
  • Revenue This Year
  • HPH N/A
  • SCLX $24.19
  • Revenue Next Year
  • HPH N/A
  • SCLX $109.90
  • P/E Ratio
  • HPH N/A
  • SCLX N/A
  • Revenue Growth
  • HPH 1722.41
  • SCLX 22.02
  • 52 Week Low
  • HPH $0.13
  • SCLX $0.21
  • 52 Week High
  • HPH $9.50
  • SCLX $2.30
  • Technical
  • Relative Strength Index (RSI)
  • HPH 39.48
  • SCLX 30.70
  • Support Level
  • HPH $0.14
  • SCLX $0.22
  • Resistance Level
  • HPH $0.16
  • SCLX $0.34
  • Average True Range (ATR)
  • HPH 0.02
  • SCLX 0.03
  • MACD
  • HPH 0.00
  • SCLX -0.00
  • Stochastic Oscillator
  • HPH 18.00
  • SCLX 8.47

About HPH HIGHEST PERFORMANCE HLDGS INC

Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. The Group operate theree segments: (1) the insurance agency segment, which mainly consists of providing agency services for a wide range of life and non-life insurance products to individual clients, (2) the claims adjusting segment, which consists of providing pre-underwriting survey services, claim adjusting services, disposal of residual value services, loading and unloading supervision services, and consulting services, and (3) the wealth management segment, which mainly consists of providing distribution and managing wealth management services. Maximum revenue is from The Insurance Agency Segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: